Answers are grounded in this paper and cite their sources.
Cross-sectional analysis reveals titer distribution variations in blood groups, indicating implications for ABO-incompatible HSCT.
Background: Isohemagglutinins directed against ABO blood group antigens play a crucial role in transfusion and transplantation. Understanding the distribution of isohemagglutinin titers in blood donors is critical, particularly in ABO-incompatible hematopoietic stem cell transplantation (HSCT). Objectives: The present study aimed to investigate the distribution of anti-A, anti-B, IgM, and IgG titers among healthy blood donors stratified by blood group, sex, and age. Methods: In this cross-sectional study, isohemagglutinin titers were measured in 1005 randomly selected donors (335 A, 335 B, and 335 O) at a single center. Titers were evaluated using the column agglutination technique, and statistical analyses were used to compare titer distributions by sex and age group. Results: The majority of donors were male (95.2%). Elevated anti-B IgM and IgG titers were significantly more common among female donors, particularly at 1:128 and 1:256 levels for IgM (P = 0.027; P = 0.012) and at the 1:1024 level for IgG (P = 0.005). The overall distribution of the ABO and Rh blood groups in this cohort was consistent with that reported in previous Turkish studies. Conclusions: Female donors demonstrated a tendency toward higher isohemagglutinin titers, although the small number of female participants limited definitive conclusions. These findings emphasize the need to screen high-titer donors, especially in the context of ABO-incompatible HSCT, and suggest that future longitudinal studies incorporating detailed immunologic histories are warranted.
No takes yet. Share an insight, caveat, or question.
Soydemir et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: